Adverum Biotechnologies, Inc. (LON:0HA3)
London · Delayed Price · Currency is GBP · Price in USD 4.288
+0.069 (1.64%)
At close: Oct 31, 2025
Adverum Biotechnologies Employees
Adverum Biotechnologies had 155 employees as of December 31, 2024. The number of employees increased by 34 or 28.10% compared to the previous year.
Employees
155
Change (1Y)
34
Growth (1Y)
28.10%
Revenue / Employee
4.71K GBP
Profits / Employee
-798.14K GBP
Market Cap
68.70M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 155 | 34 | 28.10% |
| Dec 31, 2023 | 121 | -2 | -1.63% |
| Dec 31, 2022 | 123 | -65 | -34.57% |
| Dec 31, 2021 | 188 | 21 | 12.57% |
| Dec 31, 2020 | 167 | 53 | 46.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| HSBC Holdings | 211,304 |
| Unilever | 115,964 |
| BP p.l.c. | 100,500 |
| Shell | 96,000 |
| AstraZeneca | 94,300 |
| Barclays | 93,000 |
| GSK plc | 68,629 |
| Rio Tinto Group | 60,000 |
Adverum Biotechnologies News
- 6 days ago - With Adverum, Eli Lilly Made A Small Bet That Could Pay Off Big - Seeking Alpha
- 7 days ago - ADVM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Adverum Biotechnologies, Inc. Is Fair to Shareholders - Business Wire
- 8 days ago - Eli Lilly: Is Another Monster Quarter Coming - Seeking Alpha
- 9 days ago - Adverum Biotechnologies Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Adverum Biotechnologies, Inc. - ADVM - Business Wire
- 9 days ago - $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Adverum Biotechnologies, Inc. (NASDAQ: ADVM) - PRNewsWire
- 10 days ago - Shareholder Alert: The Ademi Firm investigates whether Adverum Biotechnologies, Inc. is obtaining a Fair Price for its Public Shareholders - PRNewsWire
- 10 days ago - Eli Lilly Bets Big On Eye Gene Therapy That Could End Repeat Injections - Benzinga
- 10 days ago - Eli Lilly to buy gene therapy developer Adverum in about $262 million deal - Reuters